Ace the 2025 CCRA Exam – Get Ready to Rock Your Research Career!

The rationale behind the selection of the range of $2000 - $5000+ as typical startup fees that sponsors may pay to clinical sites is grounded in the standard practices of clinical trials and the need for sites to cover various initial costs related to study initiation.

When a clinical trial begins, sites incur several expenses that can include but are not limited to, administrative tasks, regulatory compliance, staff training, and the setup of necessary infrastructure to conduct the study. The range of $2000 - $5000+ reflects the common practice within the clinical research industry, acknowledging that fees can vary widely based on the complexity and requirements of the study, as well as the site’s resources and location.

This option captures the typical range that many sponsors would budget for initial site expenses, allowing for some variability depending on project specifics. Other ranges, such as less than $2000, would likely underrepresent the necessary funds needed for adequate preparation and setup for a clinical trial. Similarly, much higher amounts such as $5000 - $10000+ might be less frequently requisitioned for typical studies unless the trial has extensive or unique requirements that elevate the costs. Lastly, the option indicating that sites are not reimbursed does not reflect the common practice in